WO2001033217A2 - Monitoring the activity of factor xa inhibitors - Google Patents
Monitoring the activity of factor xa inhibitors Download PDFInfo
- Publication number
- WO2001033217A2 WO2001033217A2 PCT/EP2000/010646 EP0010646W WO0133217A2 WO 2001033217 A2 WO2001033217 A2 WO 2001033217A2 EP 0010646 W EP0010646 W EP 0010646W WO 0133217 A2 WO0133217 A2 WO 0133217A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasma
- fxa
- factor
- inhibitor
- clotting time
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
- G01N2333/4613—Snake venom
- G01N2333/4616—Snake venom from Russell's viper
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96444—Factor X (3.4.21.6)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
- Y10T436/201666—Carboxylic acid
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14939800A IL149398A0 (en) | 1999-11-02 | 2000-10-28 | USE OF RUSSELL'S VIPER VENOM-INDUCED PLASMA FACTOR Xa ACTIVITY TO MONITOR THE ACTIVITY OF FACTOR Xa INHIBITORS |
MXPA02003693A MXPA02003693A (en) | 1999-11-02 | 2000-10-28 | Monitoring the activity of factor xa inhibitors. |
DE60011128T DE60011128T2 (en) | 1999-11-02 | 2000-10-28 | MONITORING THE ACTIVITY OF FACTOR XA INHIBITORS |
JP2001535051A JP4463460B2 (en) | 1999-11-02 | 2000-10-28 | Use of Russell's viper snake venom-induced plasma factor Xa activity to monitor the activity of factor Xa inhibitors |
AU15157/01A AU1515701A (en) | 1999-11-02 | 2000-10-28 | Use of russell's viper venom-induced plasma factor xa activity to monitor the activity of factor xa inhibitors |
EP00977438A EP1230382B1 (en) | 1999-11-02 | 2000-10-28 | Monitoring the activity of factor xa inhibitors |
AT00977438T ATE267876T1 (en) | 1999-11-02 | 2000-10-28 | MONITORING THE ACTIVITY OF FACTOR XA INHIBITORS |
CA2389747A CA2389747C (en) | 1999-11-02 | 2000-10-28 | Use of russell's viper venom-induced plasma factor xa activity to monitor the activity of factor xa inhibitors |
US10/125,627 US7220553B2 (en) | 1999-11-02 | 2002-04-18 | Use of Russell's viper venom-induced plasma factor Xa activity to monitor the activity of factor Xa inhibitors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16316199P | 1999-11-02 | 1999-11-02 | |
US60/163,161 | 1999-11-02 | ||
GB9930535.1 | 1999-12-23 | ||
GBGB9930535.1A GB9930535D0 (en) | 1999-12-23 | 1999-12-23 | Method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/125,627 Continuation US7220553B2 (en) | 1999-11-02 | 2002-04-18 | Use of Russell's viper venom-induced plasma factor Xa activity to monitor the activity of factor Xa inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001033217A2 true WO2001033217A2 (en) | 2001-05-10 |
WO2001033217A3 WO2001033217A3 (en) | 2001-11-29 |
Family
ID=26316147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/010646 WO2001033217A2 (en) | 1999-11-02 | 2000-10-28 | Monitoring the activity of factor xa inhibitors |
Country Status (11)
Country | Link |
---|---|
US (1) | US7220553B2 (en) |
EP (1) | EP1230382B1 (en) |
JP (1) | JP4463460B2 (en) |
AT (1) | ATE267876T1 (en) |
AU (1) | AU1515701A (en) |
CA (1) | CA2389747C (en) |
DE (1) | DE60011128T2 (en) |
ES (1) | ES2222250T3 (en) |
IL (1) | IL149398A0 (en) |
MX (1) | MXPA02003693A (en) |
WO (1) | WO2001033217A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108982865A (en) * | 2018-08-16 | 2018-12-11 | 上海原科实业发展有限公司 | A kind of thrombelastogram method heparin immue quantitative detection reagent box and preparation method thereof |
US10501773B2 (en) | 2014-07-31 | 2019-12-10 | Haemonetics Corporation | Detection and classification of an anticoagulant using a clotting assay |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0705049B1 (en) * | 2007-12-28 | 2019-02-26 | Embraco Indústria De Compressores E Soluções Em Refrigeração Ltda | GAS COMPRESSOR MOVED BY A LINEAR MOTOR, HAVING AN IMPACT DETECTOR BETWEEN A CYLINDER AND PISTON, DETECTION METHOD AND CONTROL SYSTEM |
EP2316931B1 (en) * | 2009-10-30 | 2016-12-28 | Senova Gesellschaft für Biowissenschaft und Technik mbH | Polymer-coupled peptidases |
US20110136779A1 (en) * | 2009-11-23 | 2011-06-09 | Milner Peter G | Methods for stroke reduction in atrial fibrillation patients |
US20110144199A1 (en) * | 2009-11-23 | 2011-06-16 | Milner Peter G | Methods for treating atrial fibrillation |
US9549912B2 (en) | 2009-11-23 | 2017-01-24 | Armetheon, Inc. | Methods for treating atrial fibrillation |
EP2484775A1 (en) * | 2011-02-07 | 2012-08-08 | Siemens Healthcare Diagnostics Products GmbH | Heparin-insensitive method for detecting direct clotting factor inhibitors |
CN114681597A (en) * | 2022-03-11 | 2022-07-01 | 兆科药业(合肥)有限公司 | Application of viper venom hemocoagulase in preparation of drugs for reversing anticoagulation of coagulation factor Xa inhibitor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58189646A (en) * | 1982-04-01 | 1983-11-05 | Canon Inc | Magnetic toner |
US4946775A (en) | 1985-09-05 | 1990-08-07 | Yin E Thye | Composition, kit and method for assaying heparin and a method for making the composition |
US5120537A (en) * | 1989-06-14 | 1992-06-09 | Oklahoma Medical Research Foundation | Factor xa based anticoagulant compositions |
US5187155A (en) * | 1989-06-23 | 1993-02-16 | Board Of Regents, The University Of Texas System | Anticoagulant peptides |
US6103888A (en) * | 1992-07-17 | 2000-08-15 | Panorama Research, Inc. | Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
CZ297544B6 (en) | 1996-01-02 | 2007-02-07 | Aventis Pharmaceuticals Inc. | Substituted N-[(aminoiminomethyl)phenyl]propylamides or N-[(aminomethyl)phenyl]propylamides |
US5886191A (en) * | 1997-08-18 | 1999-03-23 | Dupont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof |
-
2000
- 2000-10-28 AU AU15157/01A patent/AU1515701A/en not_active Abandoned
- 2000-10-28 ES ES00977438T patent/ES2222250T3/en not_active Expired - Lifetime
- 2000-10-28 JP JP2001535051A patent/JP4463460B2/en not_active Expired - Fee Related
- 2000-10-28 MX MXPA02003693A patent/MXPA02003693A/en active IP Right Grant
- 2000-10-28 DE DE60011128T patent/DE60011128T2/en not_active Expired - Lifetime
- 2000-10-28 AT AT00977438T patent/ATE267876T1/en not_active IP Right Cessation
- 2000-10-28 EP EP00977438A patent/EP1230382B1/en not_active Expired - Lifetime
- 2000-10-28 CA CA2389747A patent/CA2389747C/en not_active Expired - Fee Related
- 2000-10-28 IL IL14939800A patent/IL149398A0/en unknown
- 2000-10-28 WO PCT/EP2000/010646 patent/WO2001033217A2/en active IP Right Grant
-
2002
- 2002-04-18 US US10/125,627 patent/US7220553B2/en not_active Expired - Fee Related
Non-Patent Citations (6)
Title |
---|
BRECHER ARTHUR S ET AL: "Coagulation protein function: IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway." ALCOHOL, vol. 13, no. 6, 1996, pages 539-545, XP001006020 ISSN: 0741-8329 * |
GONG Y Y ET AL: "Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, vol. 10, no. 3, February 2000 (2000-02), pages 217-221, XP004188820 ISSN: 0960-894X * |
JESTY J: "ANALYSIS OF THE GENERATION AND INHIBITION OF ACTIVATED COAGULATION FACTOR-X IN PURE SYSTEMS AND IN HUMAN PLASMA" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 261, no. 19, 1986, pages 8695-8702, XP001006017 ISSN: 0021-9258 * |
RAO L VIJAYA MOHAN ET AL: "Antibody induced acute factor X deficiency: Clinical manifestations and properties of the antibody." THROMBOSIS AND HAEMOSTASIS, vol. 72, no. 3, 1994, pages 363-371, XP001006019 ISSN: 0340-6245 * |
VAN WIJK E M ET AL: "MECHANIZED AMIDOLYTIC TECHNIQUE FOR DETERMINATION OF FACTOR-X AND FACTOR-X ANTIGEN AND ITS APPLICATION TO PATIENTS BEING TREATED WITH ORAL ANTI COAGULANTS" CLINICAL CHEMISTRY, vol. 26, no. 7, 1980, pages 885-890, XP002169624 ISSN: 0009-9147 * |
WALENGA J M ET AL: "ANTITHROMBOTIC ACTIVITY OF A SYNTHETIC HEPARIN PENTASACCHARIDE IN A RABBIT STASIS THROMBOSIS MODEL USING DIFFERENT THROMBOGENIC CHALLENGES" THROMBOSIS RESEARCH, vol. 46, no. 2, 1987, pages 187-198, XP001006018 ISSN: 0049-3848 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10501773B2 (en) | 2014-07-31 | 2019-12-10 | Haemonetics Corporation | Detection and classification of an anticoagulant using a clotting assay |
US10954549B2 (en) | 2014-07-31 | 2021-03-23 | Haemonetics Corporation | Detection and classification of an anticoagulant using a clotting assay |
CN108982865A (en) * | 2018-08-16 | 2018-12-11 | 上海原科实业发展有限公司 | A kind of thrombelastogram method heparin immue quantitative detection reagent box and preparation method thereof |
CN108982865B (en) * | 2018-08-16 | 2021-05-11 | 上海原科实业发展有限公司 | Thrombus elastography heparin quantitative detection kit and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
IL149398A0 (en) | 2002-11-10 |
WO2001033217A3 (en) | 2001-11-29 |
CA2389747C (en) | 2011-05-03 |
DE60011128T2 (en) | 2005-07-07 |
ATE267876T1 (en) | 2004-06-15 |
MXPA02003693A (en) | 2003-10-14 |
US7220553B2 (en) | 2007-05-22 |
ES2222250T3 (en) | 2005-02-01 |
JP4463460B2 (en) | 2010-05-19 |
US20030049704A1 (en) | 2003-03-13 |
EP1230382A2 (en) | 2002-08-14 |
CA2389747A1 (en) | 2001-05-10 |
EP1230382B1 (en) | 2004-05-26 |
AU1515701A (en) | 2001-05-14 |
DE60011128D1 (en) | 2004-07-01 |
JP2003513280A (en) | 2003-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6566140B2 (en) | Inhibition of coagulation in blood and blood products | |
Al Dieri et al. | The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding | |
JP3047120B2 (en) | Quantitative blood clotting assay for activator VII | |
Gallimore et al. | Brief Communication: Simple Chromogenic Peptide Substrate Assays for Determining Prekallikrein, Kallikrein Inhibition and Kallikrein “Like” Activity in Human Plasma | |
Goldenberg et al. | A new global assay of coagulation and fibrinolysis | |
JP2003517610A (en) | Hematological assays and reagents | |
Moalli et al. | Fibrinolysis in Critically III Patients1-3 | |
JPH07501217A (en) | How to diagnose blood clotting disorders | |
Nizzi et al. | Protein C and S deficiency | |
EP1230382B1 (en) | Monitoring the activity of factor xa inhibitors | |
EA000673B1 (en) | Factor v ratio blood test for susceptibility to thromboembolism | |
Colucci et al. | Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential | |
US5705396A (en) | Additive for diagnostic tests for determination of the coagulability of blood, method of reducing the influencing of diagnostic tests by heparin and the use of metal salts for these purposes | |
US4139415A (en) | In vitro method of determining the biological activity of factor Xa inhibitor in blood | |
Gram et al. | A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples | |
Pyrogova et al. | Level of overall hemostasis potential in donor and patient plasma in pathology | |
EP0440775B1 (en) | Factor ix chromogenic assay | |
Curvers et al. | Effects of (pre-) analytical variables on activated protein C resistance determined via a thrombin generation-based assay | |
US6426192B1 (en) | Method for the functional detection of disorders in the protein C system | |
JPH04350560A (en) | Functional measuring method for activity of protein s | |
ES2217739T3 (en) | IMPROVED BLOOD COAGULATION TEST. | |
US5114845A (en) | Assays for plasminogen activator inhibitor and soluble fibrin | |
Giddings et al. | Laboratory support in the diagnosis of coagulation disorders | |
Scully | The use of an automated analyzer in the evaluation of antithrombin III and heparin | |
Patrassi et al. | A DIC-like picture on plasma and ascitic fluid of cirrhotic patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/003693 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10125627 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000977438 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 149398 Country of ref document: IL Ref document number: 15157/01 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2001 535051 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2389747 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2000977438 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000977438 Country of ref document: EP |